Integra LifeSciences

Yahoo Finance • 8 days ago

Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer. Dr. Turner... Full story

Yahoo Finance • last month

Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial office... Full story

Yahoo Finance • 2 months ago

JMP reiterates Market Outperform rating on Integra LifeSciences stock

Investing.com - JMP Securities has reiterated its Market Outperform rating and $25.00 price target on Integra LifeSciences (NASDAQ:IART) following the company’s second-quarter 2025 financial results. The medical device manufacturer, curren... Full story

Yahoo Finance • 2 months ago

Integra LifeSciences Holding (NASDAQ:IART) Reports Q2 2025 Earnings Beat Amid Mixed Market Reaction

Integra LifeSciences Holding (NASDAQ:IART [https://www.chartmill.com/stock/quote/IART]) reported its second-quarter 2025 financial results, delivering revenue and earnings per share (EPS) that surpassed analyst expectations. However, the m... Full story

Yahoo Finance • 2 months ago

Integra LifeSciences Q2 Results Beat Expectations

(RTTNews) - Integra LifeSciences Holdings Corporation (IART), a medical technology company, Thursday reported net loss of $484.07 million or $6.31 per share for the second quarter, significantly higher than $12.40 million or $0.16 per shar... Full story

Yahoo Finance • 2 months ago

Integra LifeSciences Reports Second Quarter 2025 Financial Results

PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Seco... Full story

Yahoo Finance • 2 months ago

Integra recalls MicroMyst Applicators for sterilization concerns: FDA

[Medical team performing gastric bypass surgery] Portra/E+ via Getty Images The U.S. FDA said on Monday that Integra LifeSciences (NASDAQ:IART [https://seekingalpha.com/symbol/IART]) is recalling its MicroMyst Applicators. The recall is... Full story

Yahoo Finance • 3 months ago

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prio... Full story

Yahoo Finance • 3 months ago

INTC, PARA, MRNA and more – J.P. Morgan’s best short ideas for the second half of 2025

[Concept Of Financial Crisis] wildpixel J.P. Morgan’s U.S. equity research analysts compiled their list of “most compelling structural and tactical short ideas” for the second half of the year. Below are the short ideas, followed by a qu... Full story

Yahoo Finance • 3 months ago

Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric... Full story

Yahoo Finance • 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART).   Such investors are advised to contact Da... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Dani... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART).   Such investors are advised to contact Dan... Full story

Yahoo Finance • 5 months ago

Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, May 06, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp. (NASDAQ: IART): Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before March 11, 2019, can s... Full story

Yahoo Finance • 5 months ago

Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar Law Office

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ: AKRO): Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company. If you have... Full story

Yahoo Finance • 5 months ago

Integra LifeSciences Reports First Quarter 2025 Financial Results

PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First... Full story

Yahoo Finance • 5 months ago

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) If you have held BioAge Labs, Inc. (NASDAQ: BIOA) shares continuously since on or shortly after its September 26, 2024 IPO, you can seek corporate reform... Full story

Yahoo Finance • 5 months ago

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to... Full story

Yahoo Finance • 6 months ago

Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ... Full story